Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harpoon Therapeutics Inc (NQ: HARP )

0.7771 -0.0089 (-1.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harpoon Therapeutics Inc

< Previous 1 2 3 4 Next >
Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Harpoon Therapeutics
Via GlobeNewswire
Short Volatility Alert: Harpoon Therapeutics
On Thursday, shares of Harpoon Therapeuti (NASDAQ: HARP) experienced volatile short activity. After the activity, the stock price went down -1.59% to $0.62. The overall sentiment for HARP has been... 
Via Benzinga
Harpoon Therapeutics Presents Preclinical Results for Novel T Cell Engagers HPN217 and HPN328 at AACR 2023
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Presents Data for New ProTriTAC™ Development Candidates in TROP2- and ITGB6-expressing Solid Tumors at AACR 2023
Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic potential in a broad range of TROP2- and... 
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Announces Closing of $25 Million Private Placement
From Harpoon Therapeutics
Via GlobeNewswire
Harpoon Therapeutics Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
From Harpoon Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Sera Prognostics, Inc. (NASDAQ: SERA) shares surged 63.4% to $2.11 after the company announced top-line data from the AVERT PRETERM TRIAL. 
Via Benzinga
Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference
From Harpoon Therapeutics
Via GlobeNewswire
The 3 Most Undervalued Penny Stocks to Buy in February 2023
Here are three penny stocks in emerging sectors that look to be undervalued relative to the consensus price target of analysts. 
Via InvestorPlace
Why Heart Test Laboratories Are Trading Higher By 136%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 136% to $2.06 after Ascendant Capital initiated coverage on the stock with a Buy rating and a $3.30 price target. 
Via Benzinga
Why CN Energy Group Shares Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares rose 45.4% to $3.52 in pre-market trading after gaining around 7% on Friday. BigBear.AI recently announced a $25 million private placement. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
MarketBeat: Week in Review 12/12 - 12/16
A triple-witching day means it could be a rough end to a trading week. Before you step away for the holidays, here are some of the top articles from this week. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
7 Stocks to Add to Your 10x Watchlist
It’s always a good time to look for stocks with exceptional growth potential. Here are seven 10x stocks for your watchlist. 
Via InvestorPlace
Harpoon Therapeutics Remains Volatile After Promising News
Harpoon Therapeutics offers an example of biotech's volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga
Looking Into Harpoon Therapeutics's Recent Short Interest
Harpoon Therapeutics's (NASDAQ:HARP) short percent of float has risen 15.0% since its last report. The company recently reported that it has 563 thousand shares sold short, which is 3.22% of all... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning! 
Via InvestorPlace
Dow Surges Over 250 Points; Weber Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 250 points on Monday 
Via Benzinga
Stocks Hold Gains Ahead Of Tuesday's Economic Flurry
The major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data. 
Via Talk Markets
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.